Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supramolecular salicylic acid for treatment of papulopustular rosacea
ChiCTR2200065218Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in papulopustular rosacea comparing Supramolecular salicylic acid arm with Placebo mimic arm (2 arms). Primary endpoints: Lesion reduction rate and Total effective rate. Started Mar 2020; status: recruiting.
02
Drugs
Salvax
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on ChiCTR2200065218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065218.